Skip to NavigationSkip to content

Pharmafile - Research and Development News

This week was a bad week for clinical trials. While the FDA put Roche and AbbVie’s multiple myeloma trial on hold after a number of patient deaths...
Biogen and Eisai have announced their decision to discontinue a Phase 3 trial looking into the efficacy and safety of aducanumab in patients with...
Celgene has entered into a new three-year partnership with British artificial intelligence and drug discovery firm Exscientia to the value of at...
Antiepileptic drugs increase the risk of pneumonia in people living with Alzheimer’s disease, according to research from the University of Eastern...
Roche has secured another US approval for its immunotherapy Tecentriq (atezolizumab), as the FDA reveals its approval of the drug in combination...
The FDA has placed a partial clinical hold on studies of multiple myeloma treatment Venclexta/Venclyxto (venetoclax) following a number of patient...
The FDA has announced its decision to approve Sage Therapeutics’ intraveneous injection Zulresso (brexanolone), marking the first authorisation of...
Pfizer and Merck KGaA have chosen to discontinue the Phase 3 JAVELIN trial looking into avelumab in combination with chemotherapy as a treatment...
England’s Chief Medical Officer (CMO), Dame Sally Davies has said the legalisation of medicinal cannabis has “opened a Pandora’s Box,” with...
Death rates from breast cancer are falling faster in Britain than in any of the other six most populous countries in Europe, according to research...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches